Sprout Social, Inc. designs, develops, and operates a web-based social media management platform in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides cloud software for social messaging, data and workflows in a unified system of record, intelligence, and action. It offers AI-powered solutions, such as publishing and scheduling, social customer care, reporting and analytics, social listening and business intelligence, reputation management, social commerce, influencer marketing, employee advocacy, and automation and workflows. In addition, the company provides smart inbox, comprehensive case management, social customer relationship management, social monitoring and alerts, customer service tools, and automation; and centralized content planning, creation, and publishing, automated scheduling, content performance reporting, suggested content, message approval workflows, publishing permissions and governance, and content and asset libraries. Further, it offers social media; content performance, customer service and team, custom report builder, and reporting API; and market research, brand health, competitive insights, consumer trends, and product feedback; and social commerce, reputation and review management, mobile applications, and chat bot creation and management. Additionally, the company offers professional services consisting of consulting and training services. It serves social and community management; public relations; marketing; influencer marketing; customer service and care; commerce, sales and customer acquisition; recruiting and hiring, product development, and business strategy; and small-and-medium-sized businesses, mid-market companies, enterprises, marketing agencies, government, non-profit, and educational institutions. The company was incorporated in 2010 and is headquartered in Chicago, Illinois.

Sprout Social, Inc.

Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Seaport Therapeutics, Inc. today and set a price target of $30.00. According to Tip...

Seaport Therapeutics, Inc. (SPTX) Gets a Buy from Stifel Nicolaus

In a report released today, Elizabeth Porter from Morgan Stanley maintained a Hold rating on Sprout Social, with a price target of $11.00. Accordin...

Sprout Social (SPT) Receives a Hold from Morgan Stanley

Analysts have been eager to weigh in on the Technology sector with new ratings on Amdocs (DOX), Sprout Social (SPT) and Camtek (CAMT). Amdocs (DOX)...

Analysts Conflicted on These Technology Names: Amdocs (DOX), Sprout Social (SPT) and Camtek (CAMT)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Cloudflare (NET) and Sprout Social (SPT) with bullis...

Analysts Offer Insights on Technology Companies: Cloudflare (NET) and Sprout Social (SPT)

Sprout Social ( ($SPT) ) has issued an announcement. Sprout Social reported second-quarter 2026 results on August 6, 2026, highlighting 11% year-ov...

Sprout Social posts solid Q2 growth and profitability

The latest update is out from Spotify ( ($SPOT) ). Spotify Technology S.A. has filed a Form 6-K with the U.S. Securities and Exchange Commission fo...

Spotify Posts Strong Q2 2026 Earnings With Return to Profitability

Spotify ( ($SPOT) ) has issued an update. On August 4, 2026, Spotify reported Q2 2026 results showing solid expansion in both users and financial p...

Spotify Hits 300 Million Premium Subscribers as Q2 2026 Margins Reach Record High

In a report released today, from Oppenheimer maintained a Buy rating on Spotify, with a price target of $550.00. In addition to Oppenheimer, Spotif...

Oppenheimer Sticks to Its Buy Rating for Spotify (SPOT)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Sprout Social (SPT) and DigitalOcean Holdings (DOC...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SPT	$9.97	+4.40%	1.49M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SPT	$9.97	+4.4%	1.49M
3
4
5
6

SPT

Get Sprout Social, Inc. Data in Excel

Get Sprout Social, Inc. Data in Excel